Connection

Michael Lilly to Cyclin-Dependent Kinase Inhibitor p27

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Cyclin-Dependent Kinase Inhibitor p27.
Michael Lilly
Connection Strength
0.021
Cyclin-Dependent Kinase Inhibitor p27
  1. Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells. Mol Cancer Ther. 2009 Jun; 8(6):1473-83.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.